Intranasal immunization with peptide-based immunogenic complex enhances BCG vaccine efficacy in a murine model of tuberculosis
Open Access
- 22 February 2021
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 6 (4)
Abstract
Prime-boost immunization strategies are required to control the global tuberculosis (TB) pandemic, which claims approximately 3 lives every minute. Here, we have generated an immunogenic complex against Mycobacterium tuberculosis ( M.tb ), consisting of promiscuous T cell epitopes ( M.tb peptides) and TLR ligands assembled in liposomes. Interestingly, this complex (peptide–TLR agonist–liposomes; PTL) induced significant activation of CD4 + T cells and IFN-γ production in the PBMCs derived from PPD + healthy individuals as compared with PPD – controls. Furthermore, intranasal delivery of PTL significantly reduced the bacterial burden in the infected mice by inducing M.tb -specific polyfunctional (IFN-γ + IL-17 + TNF-α + IL-2 + ) immune responses and long-lasting central memory responses, thereby reducing the risk of TB recurrence in DOTS-treated infected animals. The transcriptome analysis of peptide-stimulated immune cells unveiled the molecular basis of enhanced protection. Furthermore, PTL immunization significantly boosted the Bacillus Calmette-Guerin–primed (BCG-primed) immune responses against TB. The greatly enhanced efficacy of the BCG-PTL vaccine model in controlling pulmonary TB projects PTL as an adjunct vaccine against TB.Keywords
Funding Information
- Department of Science and Technology, Ministry of Science and Technology (DST/INSPIRE/04/2014/002012, DST/INSPIRE/04/2014/002069)
This publication has 57 references indexed in Scilit:
- Inhibition of Nuclear Factor-Kappa B Activation Decreases Survival of Mycobacterium tuberculosis in Human MacrophagesPLOS ONE, 2013
- Treatment Outcomes for Extensively Drug-Resistant Tuberculosis and HIV Co-infectionEmerging Infectious Diseases, 2013
- A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosisNature Medicine, 2011
- Phenotypic Definition of Effector and Memory T-Lymphocyte Subsets in Mice Chronically Infected withMycobacterium tuberculosisClinical and Vaccine Immunology, 2010
- Memories that last forever: strategies for optimizing vaccine T-cell memoryBlood, 2010
- Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque modelArthritis & Rheumatism, 2010
- Severe Tuberculosis Induces Unbalanced Up‐Regulation of Gene Networks and Overexpression ofIL‐22, MIP‐1α, CCL27, IP‐10, CCR4, CCR5, CXCR3, PD1, PDL2, IL‐3, IFN‐β, TIM1,andTLR2but Low Antigen‐Specific Cellular ResponsesThe Journal of Infectious Diseases, 2008
- IL-23 and IL-17 in tuberculosisCytokine, 2008
- Early Events in Mycobacterium tuberculosis Infection in Cynomolgus MacaquesInfection and Immunity, 2006
- TLR9 signals after translocating from the ER to CpG DNA in the lysosomeNature Immunology, 2004